T. Rowe Price Associates’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,474
| Closed | -$36K | – | 3058 |
|
|
2025
Q1 | $36K | Hold |
13,474
| – | – | ﹤0.01% | 2960 |
|
|
2024
Q4 | $48K | Buy |
13,474
+2,389
| +22% | +$8.51K | ﹤0.01% | 2939 |
|
|
2024
Q3 | $53K | Hold |
11,085
| – | – | ﹤0.01% | 2918 |
|
|
2024
Q2 | $0 | Buy |
+11,085
| New | – | ﹤0.01% | 2922 |
|
|
2017
Q3 | – | Sell |
-21
| Closed | -$17K | – | 2553 |
|
|
2017
Q2 | $17K | Hold |
21
| – | – | ﹤0.01% | 2547 |
|
|
2017
Q1 | $20K | Hold |
21
| – | – | ﹤0.01% | 2562 |
|
|
2016
Q4 | $23K | Hold |
21
| – | – | ﹤0.01% | 2539 |
|
|
2016
Q3 | $23K | Hold |
21
| – | – | ﹤0.01% | 2516 |
|
|
2016
Q2 | $46K | Hold |
21
| – | – | ﹤0.01% | 2480 |
|
|
2016
Q1 | $32K | Hold |
21
| – | – | ﹤0.01% | 2483 |
|
|
2015
Q4 | $56K | Hold |
21
| – | – | ﹤0.01% | 2470 |
|
|
2015
Q3 | $103K | Buy |
21
+5
| +31% | +$24.5K | ﹤0.01% | 2404 |
|
|
2015
Q2 | $84K | Buy |
16
+1
| +7% | +$5.25K | ﹤0.01% | 2473 |
|
|
2015
Q1 | $70K | Buy |
15
+4
| +36% | +$18.7K | ﹤0.01% | 2497 |
|
|
2014
Q4 | $56K | Buy |
11
+3
| +38% | +$15.3K | ﹤0.01% | 2512 |
|
|
2014
Q3 | $47K | Hold |
8
| – | – | ﹤0.01% | 2521 |
|
|
2014
Q2 | $65K | Buy |
+8
| New | +$65K | ﹤0.01% | 2497 |
|